AP2338A - A vaccine - Google Patents

A vaccine

Info

Publication number
AP2338A
AP2338A APAP/P/2004/003131A AP2004003131A AP2338A AP 2338 A AP2338 A AP 2338A AP 2004003131 A AP2004003131 A AP 2004003131A AP 2338 A AP2338 A AP 2338A
Authority
AP
ARIPO
Prior art keywords
lipid
infectious organism
aqueous phase
phase
leukocyte fraction
Prior art date
Application number
APAP/P/2004/003131A
Other versions
AP2004003131A0 (en
Inventor
Victor Anomah Ngu
Original Assignee
Victor Anomah Ngu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victor Anomah Ngu filed Critical Victor Anomah Ngu
Publication of AP2004003131A0 publication Critical patent/AP2004003131A0/en
Application granted granted Critical
Publication of AP2338A publication Critical patent/AP2338A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A therapeutic vaccine is prepared by a method which includes the steps of extracting, with a lipid-extracting solvent, a biological fluid obtained from a person or animal infected with a lipid-containing infectious organism, the biological fluid containing the lipid-containing infectious organism, and the extraction producing an aqueous phase which contains the infectious organism with the lipid substantially removed and a lipid-containing phase, and separating the aqueous phase from the lipid-containing phase. A leukocyte fraction is isolated from the blood of the person or animal, the isolation being conducted so that the leukocyte fraction is substantially free of plasma, free lipid-containing infectious organism and free antibodies to the lipid-containing infectious organism, and at least some of the aqueous phase is combined with at least some of the leukocyte fraction to produce the vaccine.
APAP/P/2004/003131A 2003-09-11 2004-09-09 A vaccine AP2338A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA200307110 2003-09-11

Publications (2)

Publication Number Publication Date
AP2004003131A0 AP2004003131A0 (en) 2004-09-30
AP2338A true AP2338A (en) 2011-12-16

Family

ID=39787950

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2004/003131A AP2338A (en) 2003-09-11 2004-09-09 A vaccine

Country Status (3)

Country Link
AP (1) AP2338A (en)
OA (1) OA12855A (en)
ZA (1) ZA200407246B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022572A1 (en) * 1991-06-13 1992-12-23 Replico Medical Ab New hiv-1 gag and env peptides, diagnostic

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022572A1 (en) * 1991-06-13 1992-12-23 Replico Medical Ab New hiv-1 gag and env peptides, diagnostic

Also Published As

Publication number Publication date
OA12855A (en) 2006-09-15
AP2004003131A0 (en) 2004-09-30
ZA200407246B (en) 2005-06-29

Similar Documents

Publication Publication Date Title
WO2013088148A3 (en) Method of treatment employing therapeutic t cell product from mobilised donors
MY155236A (en) Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant
AUPQ846900A0 (en) A vaccine
WO2006015115A3 (en) Potent immunostimulatory extracts from microalgae
MX2012005598A (en) Hydrophilic filtration during manufacture of vaccine adjuvants.
DE602004022305D1 (en) PROCESS FOR THE SEPARATION AND RECOVERY OF 3-HYDROXYPROPIONIC ACID AND ACRYLIC ACID
Zhang et al. Adjuvant-active aqueous extracts from Artemisia rupestris L. improve immune responses through TLR4 signaling pathway
BR112012016048A2 (en) "plasmodium sp. infected reticulocyte derived exosomes, method of obtaining them and uses thereof".
WO2005058950A3 (en) Methods for generating immunity to antigen
WO2005101966A3 (en) Lipid-extracted therapeutic vaccine and method of use
WO2006045532A3 (en) Virosome particles comprising antigens from influenza virus and hepatitis b virus
WO2003090687A8 (en) Using heat shock proteins to increase immune response
MX344544B (en) Blood stage malaria vaccine.
AP2338A (en) A vaccine
TW200500331A (en) Process for the separation, by countercurrentwise liquid-liquid extraction, of a glyoxal diacetal from a crude mixture comprising it
CA2467265A1 (en) Pharmaceutical composition for enhancing immunity, and extract of poria
CY1106619T1 (en) METHOD OF PREPARING AN ISOLATED EXTRACT OF THE EUROPEAN-L CYCLAMINE PLANT AND ITS USE AS A THERAPEUTIC AGENT
DE60319840D1 (en) Poria extract free of Secolanostanderivaten containing Lanostanderivate for immune enhancement
PH12020550193A1 (en) Photochemical preparation method for autologous plasma inactivated vaccine for treating aids
CA2519012C (en) A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
ATE471155T1 (en) NEW VACCINE ADJUVANT AND ITS PRODUCTION AND USE
WO2004018699A3 (en) Extraction and concentration method
WO2009114202A3 (en) Vaccine and immunization method using plasmodium antigen 2
CN104447780B (en) A kind of method extracting sesamin from sesame
WO2001030989A3 (en) Method for creating divergent populations of nucleic acid molecules and proteins